Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer

BACKGROUND: Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. METHODS AND FINDINGS: We reviewed 227 AoV Ca patients with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Ha, Hye rim, Oh, Do-Youn, Kim, Tae-Yong, Lee, KyoungBun, Kim, Kyubo, Lee, Kyung-Hun, Han, Sae-Won, Chie, Eui Kyu, Jang, Jin-Young, Im, Seock-Ah, Kim, Tae-You, Kim, Sun-Whe, Bang, Yung-Jue
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4790941/
https://ncbi.nlm.nih.gov/pubmed/26974670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151406
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires